Cye Cornelio (@CyePharmD) header
Cye Cornelio (@CyePharmD) profile picture

Assistant Professor and Clinical Pharmacist at USF Health TCOP/ Cardiology🫀 / Board Gamer 🧩🎲 / Fitness Boxing 🥊 / Views are my own

Tampa, FL
Joined February 2019
Photo by Cye Cornelio (@CyePharmD)Photo by Cye Cornelio (@CyePharmD)Photo by Cye Cornelio (@CyePharmD)Photo by Cye Cornelio (@CyePharmD)Photo by Cye Cornelio (@CyePharmD)Photo by Cye Cornelio (@CyePharmD)Photo by Cye Cornelio (@CyePharmD)Photo by Cye Cornelio (@CyePharmD)Photo by Cye Cornelio (@CyePharmD)Photo by Cye Cornelio (@CyePharmD)
1/5 I think that the surprising findings from Lp(a)HORIZON should make us take a step back. Pelacarsen lowered Lp(a) by ~78%, but MACE was unchanged (HR 1.02). No benefit even in those with very high Lp(a). Perhaps most striking: no signal for fewer MIs - the most atherosclerosis-sensitive endpoint consistently reduced substantially in statin trials. We still don't understand the mechanisms linking Lp(a) to clinical events. HORIZON makes that uncertainty hard to ignore.
4
11
1
44
9,020
Cye Cornelio retweeted
Replying to @venkmurthy
STREAM's "noninferior" was baked in 
Max event-free time that could lose in 2 yrs: ~7.5 wks Margin pre-set: 5.2 wks (~65% of max) A perfect statin (0 MI/stroke/CV ☠️ events) gets ~3.5–4 wks 
To fail non-inferiority statins would also have to ⬇️ non-CV ☠️ (which they don’t )
4
1
18
2,587
Cye Cornelio retweeted
💊 Quadruple GDMT for HFrEF at Cost Plus generic prices:
 💵 $0.79/day · $23.83/mo · $290/yr 
📉 ↓87% HF 🏨, ↓61% all-cause 🏨 
🏥 Avoided hospital costs dwarf the drug cost 
✅ Extraordinary value. 🎯 Get every eligible patient on all 4! ❤️ 
#GDMT @costplusdrugs @mcuban
3
11
1
35
32,842
Excited to be moderating the Annual HF & CM Pecha Kucha again at #AHA26. This year’s session: Welcome to Cardio-Oncology 2.0, today at 1:30pm. Come watch @JLHarrington_MD defend her title against a competitive lineup! 🏆#ScientificSessions26
1
3
155
Congrats to @DrGuptaD! 🏆 Key takeaways from her show-stopping 🗣️on the CV complications of radiation therapy. ☢️ “Radiation waits decades to see if we’re still watching” ☢️ The RR of CAD ⬆️ 7.4% per Gy of mean heart dose ☢️ Get the mean heart dose, stratify risk, and optimize
1
1
905
Cye Cornelio retweeted
💔⏳ HF won't wait — neither should you Start all four pillars early in #HFrEF 🛠️ ARNI ➕ 🛡️ β-blocker➕ 🧪 MRA ➕ 🍬 SGLT2i Every day of delay is a day of lost benefit Plus 312 extra lives that could have been saved #GDMT #CardioTwitter
12
1
19
1,334
Rise and shine, #AHA25 Come check out the Heart Failure/Cardiomyopathy Annual Pecha Kucha! ⏰8AM / 📍260-262. This year, Pecha Kucha Says: It`s All About Cardiovascular-Kidney Metabolic Health. Join us to continue the conversation on CKM as speakers contend to earn your vote! 🏆
1
65
Congratulations 👏 to @JLHarrington_MD on winning our 7th Annual Pecha Kucha with her fantastic presentation,PREVENT the Perfect Storm: Managing Metabolic Syndrome! #AHA25
1
47
VESALIUS-CV trial: Adding evolocumab to LLRx significantly cuts LDL-C and lowers the risk of CV death/MI/ischemic stroke/ischemia-driven revasc at 4.5 years vs. placebo in high-risk patients without a prior MI or stroke. #AHA25 View the slides here: clinicaltrialresults.org/wp-…
1
26
1
60
8,319
Cye Cornelio retweeted
Diuretics in AHF: 1.loop diuretics,if refractory> 2.combine with thiazide,if refractory> 3.add dopamine,dobutamine, milrinone 4. Ultrafiltration or hemodialysis(coexist renal failure) In case of low k+>add spironolactone In case of alkalosis>add acetazolamide From Braunwald
2
41
1
128
11,634
Join Dr. @AminYehyaMD and team as they shed light on the latest #epICD recommendations, examining everything from clinical trials to real-world scenarios, patient disparities, & future methodologies. Discover who could benefit most from an ICD. jacc.org/doi/10.1016/j.jchf.… #JACCHF #GDMT #HFrEF @AndrewJSauer @BiykemB @SanaAlkhatib9
1
19
44
6,725
In pts with HFrEF and hyperkalemia (K>5 mEq/L), sodium zirconium cyclosilicate improves optimizing the use of MRA and K levels, reduces risk of hyperkalemia and need to discontinue MRA. Slides from REALIZE-K trial presented here: clinicaltrialresults.org/wp-…
23
1
59
5,818
Sacubitril-Valsartan effective in reducing risk of cardiotoxicity in high risk pts undergoing anthracycline chemotherapy, 18% absolute risk reduction with Sacubitril-Valsartan vs placebo. Dr. Marcely Gimenes Bonatto shares results of SARAH trial clinicaltrialresults.org/wp-…
6
60
2
196
25,935
Don’t miss @noshreza battle to defend her title in the 6th Annual Pecha Kucha Heart Failure Session at #AHA24! Join us for an entertaining session on infection, inflammation, and heart failure! 🦠🫀Who will be this year’s champion?🏆 @MarkDrazner @SherylChow
1
1
6
619
Congratulations to @EricAdler17 on winning this year’s Pecha Kucha Heart Failure session! Thanks to all our speakers for a great session!
1
39
Cye Cornelio retweeted
In the CLEAR randomized trial involving patients with acute myocardial infarction, colchicine did not decrease the risk of major adverse cardiovascular events over a median follow-up period of 3 years. Full trial results: nej.md/4i2U6dV
1
57
4
148
49,607
The complexities of telehealth in heart failure management highlighted by @colleenkmac at #AHA24. We need to develop interventions to overcome systemic barriers in the digital divide.
3
135
Happening now at #AHA Optimizing Heart Failure Through a Multidisciplinary approach! Learning more about international efforts to adopt GDMT from @batallah08 who established the FIRST pharmacist-led optimization clinics in the Middle East Gulf Region! #GDMTworks
1
3
322